A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2004
12/09/2004	WO2004105774A1 Oligonucleic acid-bearing composite and pharmaceutical composition containing the composite
12/09/2004	WO2004105773A2 Use of s1p
12/09/2004	WO2004105772A1 Pharmaceutical preparation for treating tropical parasitic diseases containing diaminazen-diaceturate and/or pentamidine
12/09/2004	WO2004105771A1 Combination of acetylsalicylic acid and alpha-glucosidase inhibitors
12/09/2004	WO2004105770A1 Composition comprising one or more phytosterols and/or phytostanols and glucomannan and uses of the composition in treating lipid disorders in individuals with and without type ii diabetes
12/09/2004	WO2004105769A1 Pharmaceutical composition for the treatment and/or the prevention of atherosclerosis from infectious origin
12/09/2004	WO2004105768A1 Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
12/09/2004	WO2004105767A1 Pharmaceutical composition based on agonist of benzodiazepine
12/09/2004	WO2004105766A2 Use of lornoxicam or lornoxicam analogue compounds
12/09/2004	WO2004105765A1 Macrocyclic quinazoline derivatives as antiproliferative agents
12/09/2004	WO2004105764A1 (3- ((quinazolin-4-yl) amino )-1h-pyrazol-1-yl) acetamide derivatives and related compounds as aurora kinase inhibitors for the treatment of proliferative diseases such as cancer
12/09/2004	WO2004105763A2 Use of tyrosine kinase inhibitor to treat diabetes
12/09/2004	WO2004105762A1 Medical use of diazabicyclononene derivatives as inhibitors of parasite aspartic proteases
12/09/2004	WO2004105761A1 Combined use of ecteinascidin-743 and platinum antineoplastic compounds
12/09/2004	WO2004105760A1 Use of efletirizine for treating persistent allergic rhinitis
12/09/2004	WO2004105759A2 Novel long-acting medicament combinations comprising an anticholinergic agent and a $g(b)2-adrenoreceptor antagonist for the treatment of respiratory tract diseases
12/09/2004	WO2004105758A1 Use of tripolidine in providing refreshedness on waking
12/09/2004	WO2004105757A2 Use of rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy
12/09/2004	WO2004105756A2 Combination comprising (a) a neuroprotecting agent and (b) an agent binding to gadph and pharmaceutical use thereof
12/09/2004	WO2004105755A1 Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor
12/09/2004	WO2004105754A1 Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
12/09/2004	WO2004105753A1 Antidepressant or food or beverage for antidepression
12/09/2004	WO2004105751A1 Traitement of cardiovascular pathology
12/09/2004	WO2004105750A1 3-aminomethyl-pyrrolidines as n-type calcium channel blockers
12/09/2004	WO2004105749A1 Composition having autonomic nerve modulating activity and method of use thereof
12/09/2004	WO2004105748A1 Amino acid composition and fluid replacement
12/09/2004	WO2004105747A1 Combination chemotherapy comprising capecitabine and a liposomal platinum complex
12/09/2004	WO2004105746A1 Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders
12/09/2004	WO2004105745A1 Aqueous olanexidine solution, method of preparing the same, and disinfectant
12/09/2004	WO2004105744A1 Use of iron for treating attention deficit hyperactivity disorder in children
12/09/2004	WO2004105743A1 Deramciclane-fumarate tablets
12/09/2004	WO2004105742A1 Treatment of muscle fatigue
12/09/2004	WO2004105741A1 Cosmetic and/or pharmaceutical compositions comprising dimthylsulphone for the cure and prevention of irritation, inflammation and cutaneous erythema
12/09/2004	WO2004105739A1 Compositions and foods and drinks contiaing higher fatty acid derivative
12/09/2004	WO2004105738A2 Use of tetrahydropyridine derivatives
12/09/2004	WO2004105737A2 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
12/09/2004	WO2004105735A1 Controlled release pharmaceutical compositions of tolterodine and processes for their preparation
12/09/2004	WO2004105733A1 Method and composition for stable and controlled delivery of (-)-hydroxycitric acid
12/09/2004	WO2004105731A1 Nasal formulations including a topical decongestant and a topical corticosteroid and their use in treatment of obstructive sleep apnea
12/09/2004	WO2004105728A2 Solid dispersions of cefpodoxime proxetil and processes for their preparation
12/09/2004	WO2004105727A2 Stabilized pharmaceutical product
12/09/2004	WO2004105703A2 Compounds, formulations, and methods for treating or preventing rosacea
12/09/2004	WO2004105701A2 Compositions and methods for symptomatic relief
12/09/2004	WO2004105700A2 Compounds, methods and pharmaceutical compositions for inhibiting parp
12/09/2004	WO2004105699A2 Compositions of a cyclooxygenase-2 selective inhibitor and a cannabinoid agent for the treatment of central nervous system damage
12/09/2004	WO2004105698A2 Use of phosphatase inhibitors as adjunct therapy for psychiatric disorders
12/09/2004	WO2004105696A2 Combination therapy for the treatment of neoplasms
12/09/2004	WO2004105695A2 Methods and materials for treating, detecting, and reducing the risk of developing alzheimer’s disease
12/09/2004	WO2004105694A2 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
12/09/2004	WO2004105692A2 Smooth muscle spasmolytic agents
12/09/2004	WO2004105690A2 Treatment of chronic pain associated with drug or radiation therapy
12/09/2004	WO2004105688A2 Bactericidal composition and associated method
12/09/2004	WO2004105687A2 Antimicrobial quaternary ammonium organosilane coatings
12/09/2004	WO2004105686A2 Novel topical steroid cream formulations
12/09/2004	WO2004105682A2 Carbostyril derivatives and mood stabilizers for treating mood disorders
12/09/2004	WO2004105678A2 Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions
12/09/2004	WO2004105662A1 Microbicidal compositions and methods of use
12/09/2004	WO2004105517A1 Novel nutraceutical compositions and use thereof
12/09/2004	WO2004105514A1 Wort and malt extract, process for producing the same and nonalcoholic drink or food containing the same
12/09/2004	WO2004105504A2 Dietary supplements and methods of preparing and administering dietary supplements
12/09/2004	WO2004105492A1 Aqueous compositions for disinfection and/or sterilization
12/09/2004	WO2004099280A3 Process of making press molded materials using heat activated tertiary amine urethane catalysts
12/09/2004	WO2004098594A3 Dosage form containing pantoprazole as active ingredient
12/09/2004	WO2004098581A3 Oral spray to reduce cold symptoms and duration of same
12/09/2004	WO2004098577A3 Dosage form containing (s)-pantoprazole as active ingredient
12/09/2004	WO2004094388A3 Indazole derivatives as jnk inhibitors
12/09/2004	WO2004092173A3 A2a adenosine receptor antagonists
12/09/2004	WO2004091645A3 Composition comprising rosmarinic acid, borneol and ginsenoside
12/09/2004	WO2004091522A3 Method for treating neurodegenerative disorders
12/09/2004	WO2004089901A3 Phospholipase c inhibitors for use in treating inflammatory disorders
12/09/2004	WO2004089349A3 Use of an alpha2-adrenoceptor antagonist for the treatment of epilepsy
12/09/2004	WO2004087699A3 Thiazoles useful as inhibitors of protein kinases
12/09/2004	WO2004087698A3 Thiazoles useful as inhibitors of protein kinases
12/09/2004	WO2004087119A3 Compositions containing superoxide dismutase and a selected et 5-lipoxygenase inhibitor and uses thereof
12/09/2004	WO2004085712A3 Multi-functional polymeric materials and their uses
12/09/2004	WO2004084900A8 Topical formulation and use of buspirone
12/09/2004	WO2004082591A8 Pharmaceutical composition for treatment of diabetes mellitus
12/09/2004	WO2004080446B1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine
12/09/2004	WO2004080429A3 Use of thiol-based compositions in ameliorating mucosal injury
12/09/2004	WO2004080408A3 Method of treating cancer with azaspirane compositions
12/09/2004	WO2004080176A3 Microbicidal compositions including an ionene polymer and 2,4,4’-trichloro-2’-hydroxydiphenyl ether, and methods of using the same
12/09/2004	WO2004079326A3 Anaplastic lymphoma kinase assay, reagents and compositions thereof
12/09/2004	WO2004078175A3 Pharmaceutical preparations containing thiazolidinediones for the treatment or prevention of ip-10 mediated diseases
12/09/2004	WO2004078144A3 Diphenylethylene compounds and uses thereof
12/09/2004	WO2004078108A3 Fibrate tablet and method for the production thereof
12/09/2004	WO2004075863A3 Cxcr3 antagonists
12/09/2004	WO2004071440A3 Thiazolyl-based compounds useful as kinase inhibitors
12/09/2004	WO2004071413A3 Method and composition for potentiating an opiate analgesic
12/09/2004	WO2004069794A9 New arylpiperazinyl compounds
12/09/2004	WO2004067496A9 Crystalline form of nateglinide
12/09/2004	WO2004063151A3 Novel tyrosine kinase inhibitors
12/09/2004	WO2004062593A3 Antineoplastic ether lipid compounds with modifications at the sn-2 carbon
12/09/2004	WO2004062586A3 Antineoplastic ether lipid compounds
12/09/2004	WO2004062575A3 Bicyclic carbohydrate compounds useful in the treatment of infections caused by flaviviridae sp., such as hepatitis c and bovine viral diarrhea viruses
12/09/2004	WO2004061084A8 Modulation of protein functionalities
12/09/2004	WO2004050025A3 Combination of ibuprofen and oxycodone for acute pain relief
12/09/2004	WO2004045551A3 Pharmaceutical composition
12/09/2004	WO2004030621A3 Method of treating cancer using adenosine and its analogs
12/09/2004	WO2004024168A8 Composition and method for use in intestinal cleansing procedures
12/09/2004	WO2004014336A3 Opioid-receptor antagonists in transdermal systems having buprenorphine

1 ... 4862 4863 4864 4865 4866 4867 4868 4869 4870 4871 4872 4873 4874 4875 4876 4877 4878 4879 4880 4881 4882 ... 7860